Ardagh Metal Packaging (AMBP) Q3 2026 Earnings Call Transcript

Ardagh Metal Packaging reported Q3 revenue of $1.694 billion, up 19%, and adjusted EBITDA of $213 million, up 2% and ahead of guidance; global beverage-can shipments grew 2%. The company raised FY 2026 adjusted EBITDA guidance to $785 million–$795 million and expects 3%–4% European volume growth in 2027, while planning $250 million of 2027 growth capex for European capacity. Inflation-linked coating costs are a Q4 and 2027 headwind, Americas shipments declined, and management said any refinancing of 2028 debt maturities would likely be at a higher cost; the quarterly dividend remains $0.10 per share.

Analysis

The key issue is cash conversion, not reported sales growth: much of the revenue uplift reflects input-cost pass-through, while EBITDA rose only modestly and Q4 faces a coatings-cost lag. That puts pressure on the quality of the upgrade if pass-through arrives after costs, especially with leverage still high. The 2027 European capacity build may reinforce pricing power in a tight market, but it adds near-term funding demands before management expects material contribution from the new lines in 2028. This is a timing mismatch: debt refinancing costs could rise before the capacity investment pays back.

Over the next 1–3 months, watch coating costs, working capital and Q4 EBITDA against guidance; over 6–18 months, the thesis depends on European lines ramping without oversupply and North American volumes recovering after contract resets. Can-share gains from glass support the category, but do not guarantee AMBP captures the growth if execution or customer commitments disappoint. Crown Holdings and Ball Corporation are relevant competitors to monitor for capacity additions and pricing signals.

The potential sale process adds event optionality, but is not yet a standalone investment catalyst: buyer financing costs and AMBP’s leverage may constrain bids or increase the risk that proceeds do not translate into value for minority holders. A contrarian risk is that investors focus on capacity tightness and guidance upgrades while underweighting the lag between inflation, pass-through and cash generation. Avoid chasing the upgrade until cash conversion and the Q4 bridge are clearer.

Key Decisions for Investors

• Do not add to AMBP on the earnings upgrade alone; keep exposure modest pending Q4 confirmation that EBITDA delivery and cash conversion support the increased 2027 growth capex.
• Set an alert for Q4 EBITDA below the $153–163 million guidance range, rising net leverage, or deterioration in working capital; any of these would weaken the capacity-growth thesis and could make refinancing risk more salient.
• Treat the sale process as optionality, not a base-case premium. Reassess only when there is verifiable information on bids, transaction structure and how any proceeds would affect debt and minority shareholders.
• Monitor Crown Holdings and Ball Corporation alongside AMBP for European capacity, utilization and pricing developments; evidence of supply catching up faster than demand would challenge the expected benefit from tight capacity.